Reimbursement Archives

News & Features

Rare Parents Tackling Rare Diseases

Chris Anderson -

December 23, 2022

Coronavirus

Valunomics: Key Lessons from Covid—We Need to Value Diagnostics

Kathy Vuksanaj -

February 16, 2022

Genetic research, liquid biopsy conceptual illustration

Molecular Dx

Agendia to Distribute Inivata’s RaDaR MRD and Cancer Recurrence LBx in U.S. and Europe

Chris Anderson -

April 29, 2021

News & Features

Genetic Counseling for All

Kathy Vuksanaj -

November 20, 2020

News & Features

Invitae to Acquire Clear Genetics for $50M, Adding Chatbots for Genetic Counseling

Alex Philippidis -

November 11, 2019

CellMax Life aims to win FDA approval for its circulating tumor cell (CTC) blood test designed to detect colorectal cancer. The test has been marketed for two yers in Asia

Molecular Dx

CellMax Life Launches Clinical Study for Colorectal Cancer CTC Blood Test

Clinical OMICs Staff Writer -

May 31, 2018

Myriad Genetics plans to acquire Counsyl for $375 million in cash and stock

Molecular Dx

Myriad to Acquire Counsyl for $375M, Raising Presence in Women’s Health

Clinical OMICs Staff Writer -

May 29, 2018

Genetic testing concept, DNA icon, medical doctor, isolated on white

News & Features

Anthem, UnitedHealthcare Move toward Quicker Prior Authorizations for Some Tests

Alex Philippidis -

October 2, 2017

News & Features

NAS Urges “Rapid Learning System” to Accelerate Personalized Medicine

Clinical OMICs Staff Writer -

March 7, 2016

The complexity of reimbursement for all healthcare procedures and services is something that places a great burden on the healthcare delivery system. It would seem that reform in this regard should be a priority

News & Features

To Pay or Not to Pay? Is That the Question?

Sharon F. Terry -

February 19, 2016

12 Page 1 of 2

Vitamin D May Improve Cancer Immunity by Altering the Gut Microbiome

Do COVID-19 mRNA Vaccines Boost Mucosal Immunity?

Pandemic Preparedness Needs Genomic Surveillance

Walgreens Dives into Gene and Cell Therapy Delivery

A Newly Discovered Tumor Mechanism Could Improve Immunotherapies

Reimbursement

Rare Parents Tackling Rare Diseases

Valunomics: Key Lessons from Covid—We Need to Value Diagnostics

Agendia to Distribute Inivata’s RaDaR MRD and Cancer Recurrence LBx in U.S. and Europe

Genetic Counseling for All

Invitae to Acquire Clear Genetics for $50M, Adding Chatbots for Genetic Counseling

CellMax Life Launches Clinical Study for Colorectal Cancer CTC Blood Test

Myriad to Acquire Counsyl for $375M, Raising Presence in Women’s Health

Anthem, UnitedHealthcare Move toward Quicker Prior Authorizations for Some Tests

NAS Urges “Rapid Learning System” to Accelerate Personalized Medicine

To Pay or Not to Pay? Is That the Question?

Related Content

Walgreens Dives into Gene and Cell Therapy Delivery

Metsera Launches with $290M to Develop Next Generation Weight Loss Products

Improving Gene Therapy Development for Rare Diseases

Fight Like a Mother: When an ICD-10 Code Determines Life or Death